Cargando…
Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677833/ https://www.ncbi.nlm.nih.gov/pubmed/33208184 http://dx.doi.org/10.1186/s13148-020-00964-9 |
_version_ | 1783612058955153408 |
---|---|
author | Salmon, Jessica M. Bots, Michael Vidacs, Eva Stanley, Kym L. Atadja, Peter Zuber, Johannes Johnstone, Ricky W. |
author_facet | Salmon, Jessica M. Bots, Michael Vidacs, Eva Stanley, Kym L. Atadja, Peter Zuber, Johannes Johnstone, Ricky W. |
author_sort | Salmon, Jessica M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7677833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76778332020-11-20 Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia Salmon, Jessica M. Bots, Michael Vidacs, Eva Stanley, Kym L. Atadja, Peter Zuber, Johannes Johnstone, Ricky W. Clin Epigenetics Correction BioMed Central 2020-11-18 /pmc/articles/PMC7677833/ /pubmed/33208184 http://dx.doi.org/10.1186/s13148-020-00964-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Salmon, Jessica M. Bots, Michael Vidacs, Eva Stanley, Kym L. Atadja, Peter Zuber, Johannes Johnstone, Ricky W. Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
title | Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
title_full | Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
title_fullStr | Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
title_full_unstemmed | Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
title_short | Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
title_sort | correction to: combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677833/ https://www.ncbi.nlm.nih.gov/pubmed/33208184 http://dx.doi.org/10.1186/s13148-020-00964-9 |
work_keys_str_mv | AT salmonjessicam correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia AT botsmichael correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia AT vidacseva correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia AT stanleykyml correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia AT atadjapeter correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia AT zuberjohannes correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia AT johnstonerickyw correctiontocombiningthedifferentiatingeffectofpanobinostatwiththeapoptoticeffectofarsenictrioxideleadstosignificantsurvivalbenefitinamodeloft821acutemyeloidleukemia |